PAR 41.5% 46.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm (PAR) Updated Investor Presentation, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 19 Posts.
    lightbulb Created with Sketch. 2
    PPS's strength is treating inflammatory aliments with little to no side effects (certainly not destructive ones like other treatments have yielded). I never realised there are quite a few such health conditions that could potentially be solved by this one miracle drug; Heart conditions and Chron's disease to name just a couple (See also announcement). I'm guessing this means that even the heart (muscles) can get inflamed and can result in heart failure? Imagine the potential of PPS in the future, sure it may be a number of years away by the time they go through the motions and can commercialise these un-explored avenues but potentially there may be multi blockbuster indications some time in the near future...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.135(41.5%)
Mkt cap ! $82.30M
Open High Low Value Volume
34.0¢ 49.5¢ 34.0¢ $3.506M 8.474M

Buyers (Bids)

No. Vol. Price($)
1 10000 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 147167 1
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.